Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2003
04/03/2003US20030065004 Androgen receptor modulators and methods for use thereof
04/03/2003US20030065003 Preadministering an enteric coated noroxymorphone
04/03/2003US20030065002 Analgesics; side effect reduction
04/03/2003US20030065000 Method of treating cancer
04/03/2003US20030064999 Therapy for asthma, diarrhea
04/03/2003US20030064998 Aqueous suspensions of submicron 9-hydroxyrisperidone fatty acid esters
04/03/2003US20030064996 Anticarcinogenic agents, antiinflammatory agents, anticholesterol agents, antidiabetic agents
04/03/2003US20030064993 Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
04/03/2003US20030064992 N-aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors
04/03/2003US20030064989 Inhibitors of cell proliferation, angiogenesis, fertility, and muscle contraction
04/03/2003US20030064988 Pharmaceutically active morpholinol
04/03/2003US20030064987 Immunology moderators; interleukin antagonist; anticancer agents
04/03/2003US20030064986 Method for preparing pyrimidone derivatives with antifungal activity
04/03/2003US20030064984 Anticancer agents; side effect reduction
04/03/2003US20030064983 Headaches; antiarthritic agents; respiratory system disorders; psychological disorders
04/03/2003US20030064975 Hormone composition
04/03/2003US20030064974 Cognition activator; binding of cortisol to receptor
04/03/2003US20030064973 Sexual disorders
04/03/2003US20030064971 Fusidic acid derivatives
04/03/2003US20030064970 Compounds and therapies for the prevention of vascular and non-vascular pathologies
04/03/2003US20030064968 Viricides, anticarcinogneic agents
04/03/2003US20030064967 Using probucol ester
04/03/2003US20030064966 Bone disorders; osteoporosis
04/03/2003US20030064965 Method of delivering drugs to a tissue using drug-coated medical devices
04/03/2003US20030064964 Osteoporosis; increase bone density
04/03/2003US20030064963 Aryl boronic acids for treating obesity
04/03/2003US20030064961 Anaesthetic composition
04/03/2003US20030064959 Mixture with polyacrylic acid and xanthan gumo
04/03/2003US20030064958 Pharmaceutical compositions and methods relating to fucans
04/03/2003US20030064957 Reduced toxicity; enhance efficiency; side effect reduction
04/03/2003US20030064955 Radiation resistance; prevent tissue damage; pretreatment with oxidation resistant
04/03/2003US20030064952 Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis
04/03/2003US20030064950 Methods for reducing body fat and increasing lean body mass by reducing stearoyl-CoA desaturase 1 activity
04/03/2003US20030064949 Anticancer agents
04/03/2003US20030064944 Controlling cell differentiation, cell proliferation
04/03/2003US20030064942 Methods and compositions for treating primary and secondary tumors of the central nervous system (CNS)
04/03/2003US20030064941 Avermectin and praziquantel combination therapy
04/03/2003US20030064940 Topical applying
04/03/2003US20030064938 Cardiovascular disorders; menstraution disorders; anticancer agents
04/03/2003US20030064936 Prevention hydrolysis of ceramides; topical applying to skin
04/03/2003US20030064935 Amino acid complexes of C-aryl glucosides for treatment of diabetes and method
04/03/2003US20030064934 Concurrent administering of druh and hypotonic sugar solution
04/03/2003US20030064933 Transdermal administration of ACE inhibitors
04/03/2003US20030064929 Modulating body/cranial hair growth
04/03/2003US20030064914 Copolymer-1 improvements in compositions of copolymers
04/03/2003US20030064913 Administering a an inhibitor of nuclear factor-kappa B to an individual undergoing or preparing to undergo a treatment for cancer; particularly ulcerative mouth tissue; antiinflammatory agents; side effect reduction
04/03/2003US20030064522 Diagnosisng ischemia in humans; obtain sample, detect and measure concentration of ischemic marker, compare to control, evaluate for ischemic injury
04/03/2003US20030064514 Oligonucleotide for use as antiproliferative agent
04/03/2003US20030064509 Novel chromosomal vectors and uses thereof
04/03/2003US20030064491 Nucleotide sequences coding enzymatic polypeptide for use in the production of anticarcinogenic and infection agents
04/03/2003US20030064472 Stable episomal vectors
04/03/2003US20030064430 Novel steroid-activated nuclear receptors and uses therefor
04/03/2003US20030064426 Expression vector for use in the treatment of cancer and age-related defects
04/03/2003US20030064412 123 human secreted proteins
04/03/2003US20030064407 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/03/2003US20030064374 Detecting neuronal stress in humans; obtain sample, measure phosphodiesterase concentration, evaluate for neuronal stress
04/03/2003US20030064369 Novel proteins and nucleic acids encoding same
04/03/2003US20030064123 For increasing sexual responsiveness in a mammalian female
04/03/2003US20030064122 Pharmaceutical compound, and an amount of a capsaicin compound to deter intranasal, oral, and intravenous abuse while having little or no irritating effect when administered orally or transdermally as directed
04/03/2003US20030064118 Combination of Ginseng and Ginkgo to improve cognitive skills
04/03/2003US20030064117 For oral administration, injection and topical application
04/03/2003US20030064114 For vasodilatation and inhibition of transplant rejection
04/03/2003US20030064108 Taste masked pharmaceutical compositions
04/03/2003US20030064107 Taste masked pharmaceutical liquid formulations
04/03/2003US20030064104 Shelf-stable, ready to use; to enhance delivery of active medicants/ingredients of pharmaceuticals, nutraceuticals, dietary supplements, therapeutics, diagnostics
04/03/2003US20030064103 Compositions and methods for treating vulvovaginitis and vaginosis
04/03/2003US20030064102 Antimicrobial Composition
04/03/2003US20030064100 Metronidazole antibiotic product, use and formulation thereof
04/03/2003US20030064098 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
04/03/2003US20030064097 For delivery of drugs, nutrionals, cosmeceuticals and diagnostic agents
04/03/2003US20030064095 Microfabricated nanopore device for sustained release of therapeutic agent
04/03/2003US20030064094 Agent for treating illnesses of the tracheobronchial tract, especially chronic obstructive pulmonary disease (COPD)
04/03/2003US20030064092 Pharmaceutical composition containing two active ingredients for smoking cessation
04/03/2003US20030064088 Surgically implantable and sealable drug delivery device that upon contact of its contents via an interface window or port with an organ or tissue exposes a therapeutic agent to organ or tissue surface, allowing a controlled, selective diffusion
04/03/2003US20030064084 For therapy of acne, psoriasis, seborrhea, ingrown hairs, pseudofolliculitis barbae, hyperpigmented skin, and cutaneous infection
04/03/2003US20030064082 Administering an antipsychotic agent to the individual in such a manner as to increase neurogenesis by a predetermined amount in at least one region of the brain
04/03/2003US20030064081 For therapy of skin conditions caused by allergic reactions such as eczema, poison ivy, poison oak, poison sumac, mosquito bites
04/03/2003US20030064076 Therapeutic agent for a cancer and method of screening the same, and health-care auxillary food
04/03/2003US20030064064 Administering formulation that inhibits activity of IgE(immunoglobulin E) sufficient to decrease the activity of IgE and administering to the subject second formulation amount of the antigen sufficient to modulate the immune response
04/03/2003US20030064040 Compositions and methods for inhibiting eccrine perspiration in humans
04/03/2003US20030064034 Use of compounds in a dry powder inhaler
04/03/2003US20030064032 Process for nebulizing aqueous compositions containing highly concentrated insulin
04/03/2003US20030064031 For therapy of respiratory diseases such as asthma or chronic obstructive pulmonary disease
04/03/2003US20030062483 Device and method for photoactivation
04/03/2003US20030062042 Aerosol generating method and device
04/03/2003DE20023184U1 New stable polymorphic forms of olanzapine, useful for treating psychotic conditions, mild anxiety and gastrointestinal conditions
04/03/2003CA2820170A1 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof
04/03/2003CA2726702A1 Lactam-containing compounds and derivatives thereof as factor xa inhibitors
04/03/2003CA2688860A1 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
04/03/2003CA2464436A1 Method and topical formulation for treating skin conditions associated with aging
04/03/2003CA2463039A1 1,6-naphthyridine derivatives as antidiabetics
04/03/2003CA2461903A1 Monobactam antibacterial compounds and methods of use thereof
04/03/2003CA2461870A1 Modified release dosage forms
04/03/2003CA2461865A1 Dosage form containing a confectionery composition
04/03/2003CA2461861A1 Stem cells of the islets of langerhans and their use in treating diabetes mellitus
04/03/2003CA2461806A1 Water-soluble phenylpyridazine derivatives and medicines containing the same
04/03/2003CA2461801A1 Sphingolipids
04/03/2003CA2461731A1 Pharmaceutical compositions for the treatment of urinary disorders
04/03/2003CA2461709A1 Small organic molecule regulators of cell proliferation
04/03/2003CA2461705A1 Coadministration of transport protein with conjugated cobalamin to deliver agents
1 ... 5514 5515 5516 5517 5518 5519 5520 5521 5522 5523 5524 5525 5526 5527 5528 5529 5530 5531 5532 5533 5534 ... 7860